... Bladder cancer Surgery 1975 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying...

...Tatsuo Morita; Takao Kikuchi; Shinichi Hashimoto; Yutaka Kobayashi; Akihiko Tokue The present study was designed to evaluate the role of the cytokeratin-19 fragment(CYFRA 21-1) as a tumor marker in bladder cancer. The bladder cancer cell line JMSU1 was used in the preclinical study. Subjects...

... 16010133 Key Words. Bladder cancer Therapy Surgery Abstract. The clinical findings and results obtained in a group of 100 patients with bladder tumours are presented. These patients were controlled during a 5-year period, and submitted to the same patterns of investigation and treatment. The treatment...

... after palliative cystectomy for proliferating bladder cancer if the anastomosis is performed at some distance from the common site of pelvic recurrence, and is provided with a system against back flow. In this regard the 'cuff' process seems quite satisfactory. 19 2 2019 1975 Copyright...

... to in the content or advertisements. Cancer chemotherapy Podophyllotoxin derivatives VM-26 Bladder cancer Vesical papillomatosis Eur. Urol. 1: 53-56 (1975) Preliminary Evaluation of VM-26 A New Epipodophyllotoxin Derivative, in the Treatment of Urogenital Tumours M. Pavone-Macaluso, G. Caramia, F.P...

... selectivity. The primary cellular target of photodynamic therapy seems to be the mitochondria. Bladder cancer Photodynamic therapy Phthalocyanines Mitochondria Electron microscopy 19 2 2019 1997 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part...

...Herbert Leyh; Etienne Mazeman Objective: To compare the Bard® BTA® (bladder tumour antigen) test with voided urine cytology (VUC) in the diagnosis of recurrent bladder cancer(BC). Methods: Urine specimens for the BTA test and VUC were collected on the same day as before cystoscopy from patients...

..., instructions or products referred to in the content or advertisements. Blood group isoantigens Bladder cancer Carcinoma in situ Immunochemistry Lectins Epithelial differentiation antigens Urothelial dysplasia Morphometry EurUrol 1992;21(suppl l):5-9 1616995 M. C. Sanchez-Fernandez de Sevillaa L...

...Hiroaki Shiina; Shinji Urakami; Hiroki Shirakawa; Kazushi Shigeno; Yasutoshi Himeno; Masami Mizutani; Mikio Igawa; Tomoyuki Ishibe To search for reliable parameters that reflect the biological potential of bladder cancer, the argyrophilic nucleolar organizer region (AgNOR), nuclear DNA content...

..., instructions or products referred to in the content or advertisements. Bladder wash cytology Flow cytometry Bladder cancer EurUrol 1992;21(suppl 1 ): 13 15 1616997 J. Romero L. Alos C. Mallofre M. Sole R. Gutierrez J. Alcover P. Carretero Departments of Urology and Pathology, University of Barcelona...

...M.C. Sanchez-Fernandez de Sevilla; M. Gil-Salom; M. Perez-Bacete; L. Morell-Quadreny; F. Martinez-Diaz; I. Iborra-Juan; B. Fenollosa-Entrena; A. Llombart-Bosch We carried out a DNA-ploidy, morphometric-stereologic and P-glycoprotein study on 40 newly diagnosed superficial bladder cancer patients...

... diagnosis with this staining method has reached 90%. Bladder cancer Fluorescence cytology of urine Exfoliative cytology Eur. Urol. 3: 142-144(1977) Fluorescence Urinary Cytology in Bladder Cancer J.A. Martinez-Pineiro, P. Muntanola, M. Gonzalez Martin and L. Hidalgo Service of Urology, La Paz Clinic...

...J.A. Martinez-Piñerio; P. Muntanola; L. Hidalog The immunological competence of 100 patients bearing urological cancers was evaluated by means of skin tests and serum immunoelectrophoresis. Cell-mediated immunodépressions were observed in 93.3% of prostatic cancers, 68.6% of bladder cancers...

... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Bladder wash cytology Bladder cancer Intravesical chemophrophylaxis Mitomycin C Eur...

... concluded that, in spite of remaining technical problems, paraffin-embedded tissue from bladder carcinoma is suitable for DNA FCM. Contrary to the situation in superficial bladder cancer, DNA ploidy is not related to the clinical outcome in muscle-invasive bladder carcinoma treated by neo-adjuvant chemo...

..., in order to identify those who are more likely to develop new tumours over the longer term. Such patients could be offered early prophylactic intravesical chemotherapy. The study did not substantiate tumour implantation as a factor for new tumour development in superficial bladder cancer. 1992...

...Sun-Yran Chang; Dah-Shyong Yu; Cheng-Ping Ma; Ming-Yi Liau The intravesical instillation of bacillus Calmette-Guérin (BCG) has proved to be an effective modality for prophylaxis of recurrent superficial bladder cancer and treatment of carcinoma in situ. The domestic BCG, named Taipei- NIPM, which...

...%) with aneu ploid DNA content. In this latter group of 10 cases a multiclonal DNA-aneu ploid pattern was found, with a significant difference (p < 0.001). Flow cytometry Ploidy Bladder cancer Staging Research Paper EurUrol 1992;21:58-63 1605115 R. Campanellaa A. Russob S. Plajab V. Bazanb C...

...S. Ozono; E. Okajima; Y. Hirao; K. Babaya; S. Komada; H. Matsuki; S. Takahashi; H. Ohishi; T. Yoshioka Transcatheter arterial embolization was performed in a total of 70 patients with invasive bladder cancer from October 1980 to December 1987. It was performed as a part of multidisciplinary...

... evaluated from those with tumor extended outside (pT3b). The results obtained with this subdivision showed that pT3a patients have almost the same survival rate as pT2 patients. From these results it is concluded that radical cystectomy is a satisfactory curative treatment of bladder cancer confined...